Schroers-Martin JG, Merryman R, Spinner MA, Yeung A, Chang C, Silin C, Powell M, Armand P, Shipp M, Advani R. Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphoma. haematol [Internet]. 2020Sep.10 [cited 2026Jul.9];. Available from: https://haematologica.org/article/view/14270